Literature DB >> 27523741

Assessing determinants of the intention to accept a pertussis cocooning vaccination: A survey among Dutch parents.

Olga Visser1, Janneke Kraan2, Reinier Akkermans3, Robert A C Ruiter4, Koos van der Velden5, Jeannine L A Hautvast6, Marlies E J L Hulscher7.   

Abstract

INTRODUCTION: Pertussis cocooning is one of the strategies aiming to prevent the potential harm of pertussis in infants by vaccinating (among others) their parents. Several countries adopted this strategy, but uptake is a problem. Determinants of parental uptake are important in the design of an effective vaccination programme. Therefore, this study aims to assess parents' intention to accept a pertussis cocooning vaccination and its determinants.
METHODS: A 98 item questionnaire was developed based on a theoretical framework, assessing parents' intention to accept a pertussis cocooning vaccination and its personal and psychosocial determinants. In addition, beliefs underlying parents' attitude towards pertussis cocooning vaccination were assessed. Both logistic and linear regression analysis were used to assess univariate and multivariate associations amongst study variables.
RESULTS: Parents returned 282 questionnaires. The majority of the parents (78%) reported a positive intention to accept a pertussis cocooning vaccination. Attitude (OR 6.6, p<.001), anticipated negative affect in response to non acceptance (OR 1.65, p<.001), anticipated negative affect in response to acceptance (OR 0.55, p .040) and decisional uncertainty (OR 0.52, p .002) were significantly associated with intention. General vaccination beliefs (β 0.58, p<.001), moral norm (β 0.22, p<.001), perceived susceptibility of pertussis in children (β 0.10, p.004), and efficacy outcome expectations (β 0.15, p.011) were significant correlates of attitude towards pertussis cocooning vaccination.
CONCLUSION: The parental intention to accept a pertussis cocooning vaccination in this study is rather high. Targeting the identified determinants of parents' acceptance in a pertussis cocooning vaccination programme is crucial to secure that intention is translated into actual vaccination uptake.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Behaviour change; Beliefs; Immunization; Implementation science; Pertussis; Theory-based behavioural interventions; Vaccination; Whooping cough

Mesh:

Year:  2016        PMID: 27523741     DOI: 10.1016/j.vaccine.2016.07.024

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Psychosocial and organizational barriers and facilitators of meningococcal vaccination (MenACWY) acceptance among adolescents and parents during the Covid-19 pandemic: a cross-sectional survey.

Authors:  Veja Widdershoven; Rianne P Reijs; Amanja Verhaegh-Haasnoot; Robert A C Ruiter; Christian J P A Hoebe
Journal:  BMC Infect Dis       Date:  2022-05-31       Impact factor: 3.667

2.  Investigating Italian parents' vaccine hesitancy: A cross-sectional survey.

Authors:  Francesco Napolitano; Alessia D'Alessandro; Italo Francesco Angelillo
Journal:  Hum Vaccin Immunother       Date:  2018-05-14       Impact factor: 3.452

3.  Intention to accept pertussis vaccination among Chinese people older than age 5.

Authors:  Xuewen Tang; Tingting Tang; Rui Yan; Yang Zhou; Xuan Deng; Hanqing He
Journal:  Hum Vaccin Immunother       Date:  2021-01-15       Impact factor: 3.452

4.  Attributes influencing parental decision-making to receive the Tdap vaccine to reduce the risk of pertussis transmission to their newborn - outcome of a cross-sectional conjoint experiment in Spain and Italy.

Authors:  Edouard Ledent; Giovanni Gabutti; Esther W de Bekker-Grob; Juan Luis Alcázar Zambrano; Magda Campins Martí; María Teresa Del Hierro Gurruchaga; María José Fernández Cruz; Giuseppe Ferrera; Francesca Fortunato; Pierfederico Torchio; Giorgio Zoppi; Christian Agboton; Walid Kandeil; Federico Marchetti
Journal:  Hum Vaccin Immunother       Date:  2019-04-15       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.